![]() Learn more about our upcoming webinars at. In the coming weeks, we will continue to provide webinars with updated information on relevant topics. This episode was recorded during a live webinar. Steven Katz of REI Protect joins in the discussion, offering his perspective on risk mitigation and ensuring your practice reduces liability in any way it can during these unprecedented times. On this special episode of Inside Reproductive Health, Griffin talks to Jeff Issner and Taylor Stein of EngagedMD, a company that has developed an application that not only provides digital consent forms, but also goes the extra mile in patient education. And thanks to new innovations making consents available online, clinics are able to get patients ready for treatment, while remaining in good legal-standing. ![]() Thanks to applications such as Zoom, clinics are able to conduct consults or relay testing results. Thankfully, there has been a surge in interest in using digital technology to keep some semblance of normal for patients seeking treatment. Patients everywhere have been told that treatments have been put on hold and have been left in limbo. We all have our expertise in different areas and our experience in different areas and now's the time to be talking about our approaches, what we're doing, sharing our ideas, and really, really working together to try to get through this and to put practices and patients in the best positions possible.” “.this is an unprecedented time for everybody. Doody talk about entrepreneurship in the fertility field and then, we dig into conflicts of interest in the field: what is acceptable and what isn’t. He is also the Chief Scientist of Global Fertility and Genetics. He is also co-creator of Effortless IVF, which is a new ART technology treatment that uses INVOcells. Doody founded Care Fertility in Fort Worth, Texas with his wife, Kathy, in 1989. On this episode of Inside Reproductive Health, Griffin talks to Dr. So how do doctors draw the line? How are they able to ensure they are keeping the patient’s best interest at heart, and not just making decisions that are beneficial to the physician? No matter what the venture is, there is always the potential for creating a conflict of interest. From investing in pharmacies to serving as medical directors for new ART companies to starting software companies, REIs can be found doing a lot. David Sable at or find him on Twitter Read More →ĭespite busy schedules taking care of patients and often running clinics themselves, it’s not uncommon to see doctors getting involved in ventures outside of their clinic’s four walls. Sable is a life sciences portfolio manager, an adjunct at Columbia University, and serves as director, advisor, and board member for a wide range of biotech and advocacy organizations. Sable also sought to help the field as a whole by finding investors to create new technology to increase the amount of people served by the field. In addition to serving as a reproductive endocrinologist, Dr. David Sable co-founded and served as director of the Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center in New Jersey, was founder of Assisted Reproductive Medical Technologies, and was co-founder of Reprogenetics. Sable shares his biggest hopes for the fertility field and what entrepreneurs need to do to get it to the next level.ĭr. From lessons from oncology to bottlenecks holding us back, Dr. They discuss what it is going to take to scale to a million cycles in the US and 15 million around the world. David Sable, a retired REI and current serial investor in biotechnology and other companies that aim to make the field more efficient and accessible by the patients we aim to treat. Venture Capital has been slowly making its way into the field over the last several years.
0 Comments
Leave a Reply. |